Covaxin, an inactivated SARS-CoV-2 vaccine and the only vaccine to have been proven effective against all variants including the Delta variant in a Phase III clinical study, deserves to be tested in clinical trials in the U.S. for potential CDC/FDA approval for use in the U.S. As we are about to celebrate the one-year anniversary
The American public deserves more COVID-19 vaccine options originally appeared in KevinMD.com.
